Literature DB >> 6714534

Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia.

B Vasquez, E V Flock, P J Savage, M Nagulesparan, L J Bennion, H R Baird, P H Bennett.   

Abstract

To determine whether sustained control of hyperglycaemia in Type 2 (non-insulin-dependent) diabetic patients would diminish proteinuria, the effect of hypocaloric diet therapy (500 kcal/day) on proteinuria was assessed in obese, Type 2 diabetic patients (n = 24) and compared with results obtained for obese subjects with normal glucose tolerance (n = 7) and impaired glucose tolerance (n = 6). Diet therapy of similar mean duration resulted in similar percentage weight loss (mean percentage of original weight +/- SEM) in diabetic (13.6 +/- 1.6%), glucose intolerant (16.4 +/- 3.3%) and obese non-diabetic (11.0 +/- 1.0%) subjects. Following therapy, plasma glucose concentrations 2h after an oral glucose load declined in the diabetic (18.34 +/- 0.81 to 10.67 +/- 0.50 mmol/l, mean +/- SEM; p less than 0.001) and in the glucose intolerant subjects (10.2 +/- 0.3 to 7.3 +/- 0.4 mmol/l, p less than 0.01) while remaining unchanged in the obese non-diabetic subjects (7.09 +/- 0.23 to 6.77 +/- 0.32 mmol/l, NS). Concentrations of total protein of plasma origin and albumin in 24-h urine collections were quantified by a sensitive immunonephelometric assay using specific antisera. Initially, 24-h excretion of total protein and albumin were elevated in the diabetic [mg protein/24 h; (median +/- 95% confidence limits): 63 (42-138), p less than 0.05; albumin: 26 (14-56), p less than 0.05] and glucose intolerant subjects [protein: 52 (13-92), NS; albumin: 24 (3-61), NS] compared with the non-diabetic subjects [protein: 20 (5-38); albumin: 6.2 (3.5-9.5)].(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714534     DOI: 10.1007/bf00281119

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Automated immunochemical method for determination of urinary protein of plasma origin.

Authors:  L M Killingsworth; C E Britain; L L Woodard
Journal:  Clin Chem       Date:  1975-09       Impact factor: 8.327

2.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

3.  Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.

Authors:  P J Savage; L J Bennion; E V Flock; M Nagulesparan; D Mott; J Roth; R H Unger; P H Bennett
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

4.  Long-term juvenile diabetes treated with unmeasured diet.

Authors:  H C Knowles
Journal:  Trans Assoc Am Physicians       Date:  1971

Review 5.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

6.  Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy.

Authors:  P J Savage; L J Bennion; P H Bennett
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

Review 7.  Diabetic regulation and its relationship to microangiopathy.

Authors:  P Raskin
Journal:  Metabolism       Date:  1978-02       Impact factor: 8.694

8.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

Authors:  G C Viberti; J C Pickup; R J Jarrett; H Keen
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

9.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.

Authors:  G C Viberti; R W Bilous; D Mackintosh; J J Bending; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

10.  Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy.

Authors:  W V Tamborlane; J E Puklin; M Bergman; C Verdonk; M C Rudolf; P Felig; M Genel; R Sherwin
Journal:  Diabetes Care       Date:  1982 May-Jun       Impact factor: 19.112

View more
  37 in total

Review 1.  ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

Authors:  C C Kelleher
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Genetic variants in nicotinic acetylcholine receptor genes jointly contribute to kidney function in American Indians: the Strong Heart Family Study.

Authors:  Yun Zhu; Jingyun Yang; Shengxu Li; Shelley A Cole; Karin Haack; Jason G Umans; Nora Franceschini; Barbara V Howard; Elisa T Lee; Jinying Zhao
Journal:  J Hypertens       Date:  2014-05       Impact factor: 4.844

3.  A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians.

Authors:  Yunhua L Muller; Paolo Piaggi; Robert L Hanson; Sayuko Kobes; Shujera Bhutta; Maryam Abdussamad; Tennille Leak-Johnson; Matthias Kretzler; Ke Huang; E Jennifer Weil; Robert G Nelson; William C Knowler; Clifton Bogardus; Leslie J Baier
Journal:  Hum Mol Genet       Date:  2015-02-06       Impact factor: 6.150

4.  Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment.

Authors:  A Schmitz; H H Hansen; T Christensen
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

5.  Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.

Authors:  Helen C Looker; Michael Mauer; Pierre-Jean Saulnier; Jennifer L Harder; Viji Nair; Carine M Boustany-Kari; Paolo Guarnieri; Jon Hill; Cordell A Esplin; Matthias Kretzler; Robert G Nelson; Behzad Najafian
Journal:  J Am Soc Nephrol       Date:  2019-06       Impact factor: 10.121

6.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

Authors:  M Marre; H Leblanc; L Suarez; T T Guyenne; J Ménard; P Passa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

7.  Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Pomerleau; M Verdy; D R Garrel; M H Nadeau
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

8.  Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.

Authors:  L Niskanen; M Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; K Pyörälä
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

9.  Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes.

Authors:  Meda E Pavkov; Clinton C Mason; Peter H Bennett; Jeffrey M Curtis; William C Knowler; Robert G Nelson
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152

10.  A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.

Authors:  Jiaqiong Xu; Elisa T Lee; Richard B Devereux; Jason G Umans; Jonathan N Bella; Nawar M Shara; Jeunliang Yeh; Richard R Fabsitz; Barbara V Howard
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.